Health outbreak at luxury destination prompts new travel advisory

While the U.S. State Department issues travel advisories based on the political and safety situation in a given country, the Centers for Disease Control and Prevention (CDC) rates and releases warnings about health-related dangers in different parts of the world. Assigned to specific outbreaks rather than individual countries, the rankings range from level one’s “practice … Read more

IFITMs Inhibit Chikungunya & Zika Viruses via TLR/RLR Pathways

Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates “`html Unlocking Immunity: IFITM Proteins and the Fight Against Chikungunya Virus unveiling the potential: Ifitm proteins as chikungunya virus inhibitors Table of Contents 1. unveiling the potential: Ifitm proteins as chikungunya virus inhibitors 2. What specific challenges are associated with using IFITM proteins as … Read more

2025 Vaccine Schedule: ACIP’s Updated Recommendations

Archyde ACIP Updates: New Meningococcal Vaccine option, Expanded RSV Recommendations Published: 2025-05-01 16:32:26 This report summarizes significant changes discussed at the April 2025 Advisory Committee on Immunization Practices (ACIP) meeting. The transcript has been edited for clarity. The April ACIP meeting, the first under the new management, convened after a two-month delay. Despite its compressed … Read more

Acute Arthritis in Traveller Reveals Rare Viral Infection

Key Takeaways In cases of acute arthritis, it is crucial to consider infectious causes, particularly viral infections. This recommendation was made by a team of rheumatologists led by Dr Matthias Wahle, head and senior physician in the Department of Internal Medicine at University Hospital Augsburg, Augsburg, Germany, based on the case of a 59-year-old woman.  … Read more

Chikungunya Vaccine Shows Promise in Adults

TOPLINE: The chikungunya virus virus-like particle (CHIKV VLP) vaccine achieved 100% seroconversion in adults who had previously received alphavirus vaccines and alphavirus vaccine–naive control individuals, with the previous recipients showing a faster immune response. Moreover, both groups had similar safety profiles. METHODOLOGY: Researchers conducted an open-label, phase 2, randomized controlled trial at two clinical sites … Read more